Efficacy and Safety of Chemically Synthesized Semaglutide Injection (HD1916) for the Treatment of Obesity: A Multicenter, Randomized, Phase III Trial.

已完结 20 由 TI__ME 发布于 2026/10/30 0:15:07

DOI:10.1111/dom.71354
作者：Leili Gao,?Yujin Ma,?Qiu Zhang,?Jiarui Li,?Lian Guo,?Lihui Zhang,?Hongwei Jin,?Yan Wang,?Chengyan Jiang,?Wenxiu He,?Ting Quan,?Xiaofang Zhang,?Mengya Cao,?Weihong Gu,?Linong Ji
文献类型：期刊论文
补充材料：只需要正文

其它数据库

Abstract：Aims: To evaluate whether HD1916, a chemically synthesised semaglutide, is therapeutically equivalent to the reference product semaglutide (Wegovy) in body weight reduction among Chinese adu

应助信息

19小时前

hxie

22d06d37d3f711f1a21d208810ba6e4f.pdf 已采纳

1天前

Book学术机器人

2026/10/30 0:15:07 未找到该文献，机器人已退出，请等待人工下载

2026/10/30 0:15:07 Book学术AI机器人收到请求，开始寻找文献

2026/10/30 0:15:07 已向机器人发送请求

1天前

TI__ME 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Breast Cancer Screening in Survivors of Childhood Cancer.